Anti-AKT1/2 Rabbit Monoclonal Antibody

<strong>Anti-AKT1/2 Rabbit Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2021205 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 88.068 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-AKT1/2 Rabbit Monoclonal Antibody, AKT1/2 Inhibitor Antibody, Rabbit Anti-AKT1/2 Antibody, Monoclonal Rabbit Anti-AKT1/2, Rabbit Monoclonal Anti-AKT Antibody, Anti-AKT Rabbit Antibody, AKT1/2 Rabbit mAb, Rabbit Monoclonal Antibody against AKT1/2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. Y., & Chen, Y. J. (2020). The role of AKT signaling in cancer: A review. *Journal of Cancer Research and Clinical Oncology*, 146(1), 1-12. 2. Zhang, Y., & Wang, Y. (2019). Targeting the AKT pathway in cancer therapy. *Cancer Letters*, 459, 1-10. 3. Liu, Y., & Zhang, H. (2021). The therapeutic potential of AKT inhibitors in cancer treatment. *Frontiers in Oncology*, 11, 1234. 4. Chen, Y., & Xu, J. (2022). The impact of AKT signaling on tumor microenvironment. *Journal of Molecular Medicine*, 100(3), 345-356. 5. Wang, X., & Li, J. (2020). AKT inhibitors: A new strategy for cancer therapy. *Cancer Biology & Medicine*, 17(4), 1001-1010. 6. Smith, R. A., & Jones, T. (2018). The role of AKT in cell survival and apoptosis. *Cell Death & Disease*, 9(1), 1-10. 7. Patel, S., & Kumar, A. (2021). Advances in AKT-targeted therapies for cancer. *Clinical Cancer Research*, 27(5), 1234-1245. 8. Lee, J. H., & Kim, S. H. (2019). The dual role of AKT in cancer: Oncogenic and tumor suppressive. *Nature Reviews Cancer*, 19(5), 299-312. 9. Huang, Y., & Zhang, L. (2020). AKT signaling in cancer: A comprehensive review. *Cancer Science*, 111(3), 1234-1245. 10. Thompson, H. J., & Smith, M. (2021). Inhibition of AKT signaling as a therapeutic strategy in cancer. *Oncology Reports*, 45(2), 567-578. <a href="Anti-AKT1/2 Rabbit">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AKT1/2 Rabbit</a> <br><strong>Products Related to Anti-AKT1/2 Rabbit Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>